Company
Pharvaris
Pharvaris is a late-stage biopharmaceutical company focused on advancing oral investigational therapies for people living with bradykinin-mediated angioedema.
Also known as Pharvaris GmbH
- Business model
- B2B
- Headquarters
- Zug, Switzerland
- Founded
- 2016
- Customers
- people living with bradykinin-mediated angioedema
- Legal name
- Pharvaris GmbH
- pharvaris.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Pharvaris is a late-stage biopharmaceutical company focused on advancing oral investigational therapies for people living with bradykinin-mediated angioedema. By targeting a clinically-validated pathway in hereditary angioedema (HAE), we are developing orally administered bradykinin B2 receptor antagonists designed to help address significant unmet needs and expand treatment options for people living with bradykinin-mediated angioedema.
Loading relationship preview